Maintaining Consistent Sleep Could Help Regulate Glucose Disposal Rate

Recent clinical evidence suggests that for patients struggling with metabolic syndrome and insulin resistance, one of the biggest parts of insulin management a pharmacist might need to discuss could be the importance of sleep. A comprehensive analysis of the National Health and Nutrition Examination Survey identified a precise inflection point for metabolic health, revealing an inverted U-shaped relationship between weekday sleep duration and the estimated glucose disposal rate (eGDR), a reliable surrogate marker for insulin resistance.

“Chronic sleep deprivation can lead to a range of adverse health consequences, including CVD [cardiovascular disease], MetS [metabolic syndrome], and mood disorders,” the study authors said.¹ “To compensate for weekday sleep loss, many individuals attempt weekend catch-up sleep.”

For pharmacists who sit at the intersection of medication therapy and lifestyle counseling, understanding this threshold is becoming essential for effective diabetes and cardiovascular risk management.

The eGDR serves as a practical clinical tool, calculated using a patient’s waist circumference, hypertension status, and glycated hemoglobin (HbA_1c). Because these data points are frequently accessible to pharmacists during routine medication reviews, the eGDR allows for the early identification of individuals at high risk for cardiovascular disease and metabolic dysfunction.¹

The research indicates that for individuals sleeping less than 7.32 hours on weekdays, every additional hour of sleep significantly improves eGDR and, by extension, insulin sensitivity. Conversely, exceeding this threshold is associated with a decline in metabolic health, suggesting that oversleeping can be just as detrimental to glucose utilization as deprivation.¹

This delicate metabolic balance is further complicated by the common practice of weekend catch-up sleep. Although many patients attempt to catch up on sleep on Saturdays and Sundays, the latest findings suggest this strategy is only beneficial in moderation.¹

For those with significant weekday sleep debt, a moderate catch-up of 1 to 2 hours can improve eGDR levels. However, exceeding 2 hours of catch-up sleep, or attempting it when weekday sleep is already sufficient, can actually exacerbate negative metabolic correlations. This phenomenon is often attributed to social jetlag, where the discrepancy between biological and social clocks leads to circadian misalignment, disrupting the coordinated expression of core clock genes such as CLOCK and BMAL1.^1,2

The underlying physiological mechanisms linking sleep to insulin resistance are multifactorial and involve a cascade of inflammatory and hormonal shifts. Insufficient sleep is known to trigger a rise in inflammatory markers, specifically C-reactive protein and serum amyloid A. These elevated markers are part of a signaling cascade that connects sleep loss to obesity and type 2 diabetes.³

Furthermore, sleep restriction induces acute insulin resistance by increasing sympathetic activation and altering the hypothalamic-pituitary-adrenal axis, which leads to elevated evening cortisol levels and reduced suppression of nonesterified fatty acids. In patients with existing abnormal glucose tolerance, sleep disturbances are also associated with a lower response of glucagon-like peptide-1 to glucose challenges, further impairing the body's ability to manage blood sugar.^2,3

In response to this growing body of evidence, the 2024 American Diabetes Association and European Association for the Study of consensus guidelines have officially incorporated sleep as a central pillar of type 2 diabetes management, placing it on par with diet and physical activity. Pharmacists are encouraged to utilize the five S's framework—survey, support, shared decision-making, solutions, and signpost—to integrate sleep hygiene into their clinical practice.²

This might involve screen-testing for sleep disorders like obstructive sleep apnea or recommending behavioral interventions such as cognitive behavioral therapy for insomnia, which has shown promise in improving both sleep quality and HbA_1c levels.²

Ultimately, the role of the pharmacist is evolving to include the management of preventable risk factors that traditional pharmaceutical therapies might not fully address. By monitoring eGDR and discussing the nuances of both weekday sleep quantity and the potential traps of excessive weekend recovery, pharmacists can provide more personalized care. As the global prevalence of metabolic syndrome continues to rise, recognizing that adequate, consistent sleep of approximately 7 hours is necessary for maintaining metabolic homeostasis may be one of the most impactful interventions a health care provider can offer.^1-3

“These correlational findings suggest that sleep patterns, particularly weekend recovery sleep, may be relevant for metabolic regulation in diabetes and could inform considerations for health care professionals in managing patient care,” the study authors said.¹

READ MORE: Insulin Management Resource Center

Are you ready to elevate your pharmacy practice? Sign up today for our free Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips straight to your inbox.

REFERENCES

1. Fan Z, Wei R, Chen T, et al. Association of weekday sleep duration and estimated glucose disposal rate: the role of weekend catch-up sleep. BMJ Open Diabetes Res Care. 2026;14(2):e005692. Published 2026 Mar 3. doi:10.1136/bmjdrc-2025-005692

2. Henson J, Covenant A, Hall AP, et al. Waking Up to the Importance of Sleep in Type 2 Diabetes Management: A Narrative Review. Diabetes Care. 2024;47(3):331-343. doi:10.2337/dci23-0037

3. Singh T, Ahmed TH, Mohamed N, Elhaj MS, Mohammed Z, Paulsingh CN, Mohamed MB, Khan S. Does Insufficient Sleep Increase the Risk of Developing Insulin Resistance: A Systematic Review. Cureus. 2022 Mar 26;14(3):e23501. doi: 10.7759/cureus.23501. PMID: 35494895; PMCID: PMC9036496.